[1] The purpose of this discussion focused on the pathophysiology of sepsis is to provide the neonatal care provider with information, now widely accepted on the pathophysiology of sepsis in ...

Adrenomed’s goal is to fill the gap in patient treatment further downstream of inflammation with Adrecizumab, the first sepsis therapy candidate to target an important causal pathophysiology of ...

Application of immunomodulation strategies in clinical practice requires in-depth knowledge of the pathogenesis cascade of sepsis that it is far more complex than the usually applied simplistic ...